Be vigilant of synthetic Alpha-Glyceryl Phosphoryl Choline, says Chemi Nutra

August 14, 2019

Chemi Nutra warns that synthetic Alpha-Glyceryl Phosphoryl Choline is making its way into the market by posing as the company’s branded ingredient. 

Chemi Nutra, manufacturer of the branded all-natural, GRAS, and IGEN Non-GMO Certified AlphaSize Alpha-Glyceryl Phosphoryl Choline, warns that synthetic Alpha-Glyceryl Phosphoryl Choline (A-GPC) is making its way into the market, largely through deceptive practices. Sellers of synthetic A-GPC have been known to fraudulently provide Chemi Nutra’s regulatory documentation rather than their own, says the firm.

For those that may not understand the risks of using synthetic A-GPC in a dietary supplement product, Chemi Nutra explains that the raw materials used to manufacture synthetic A-GPC may contain genotoxic and endotoxic impurities that can make their way into the final product. Chemi Nutra’s AlphaSize A-GPC, on the other hand, is the only A-GPC ingredient whose GRAS dossier, related to safety, was submitted in its entirety to FDA for review.

“Nearly 20 years ago, Chemi Nutra introduced our branded, high quality, AlphaSize A-GPC, ‘The Original A-GPC,’ to the supplement, food, and beverage industries. It is proven safe and legal for use, unlike generic, fully synthetic, A-GPC, and it is patented and produced in our own facility in Italy, where any customer can audit its production and see firsthand our extreme attention to quality control,” said Scott Hagerman, president of Chemi Nutra, in a press release. “Consumers look for the AlphaSize A-GPC logo on finished product labels, as their assurance of highest quality, safety, and validated health benefits. We have sponsored numerous published studies on our branded A-GPC, demonstrating its impressive mental performance and physical performance benefits."

"Chemi Nutra is now taking legal and regulatory actions, represented by the prominent law firm, Rivkin Radler LLP, and we will be taking additional wider ranging actions in the very near future,” adds Hagerman.